vaccin
effect
method
prevent
control
infecti
diseas
lead
often
erad
contagi
factor
environ
reason
vaccin
play
profound
role
improv
human
anim
health
world
health
organ
report
licens
vaccin
common
danger
maladi
avail
market
induct
effect
immun
respons
specif
antigen
consid
main
goal
vaccin
approach
provid
protect
particular
infect
recent
mani
research
focus
interest
develop
new
safe
mucos
administ
vaccin
product
less
less
labori
easili
appli
addit
vaccin
thought
prevent
carriag
pathogen
popul
limit
influenc
matern
antibodi
infant
often
vaccin
base
directli
pathogen
antigen
howev
prepar
administ
oral
induc
low
nonexist
immun
respons
reason
low
efficaci
probabl
connect
ineffect
microbi
adsorpt
fast
antigen
degrad
induct
mucos
toler
yet
although
develop
effici
oral
vaccin
may
pose
mani
difficulti
advantag
approach
still
predomin
current
two
major
trend
develop
mucos
appli
vaccin
one
base
synthet
system
oral
antigen
deliveri
emuls
microparticl
complex
liposom
saroja
et
al
strategi
reli
live
viral
bacteri
vector
enabl
antigen
product
vivo
case
pathogen
bacteria
often
use
vaccin
develop
construct
stabl
recombin
strain
synthes
suffici
antigen
amount
advers
effect
vaccin
host
environ
problemat
innov
solut
use
lactic
acid
bacteria
lab
possess
gra
statu
mean
nonpathogen
applic
safe
human
anim
absenc
lipopolysaccharid
lp
cell
wall
great
advantag
elimin
risk
endotox
shock
addit
food
industri
long
success
experi
product
safe
storag
bacteria
simplifi
prepar
shelv
potenti
vaccin
holzapfel
et
al
lab
mostli
known
widespread
use
starter
strain
food
feed
ferment
technolog
also
probiot
effect
speci
strain
human
anim
health
merceni
et
al
lab
quit
acid
resist
enabl
effect
surviv
passag
stomach
vital
point
oral
vaccin
administr
addit
mani
differ
approach
develop
improv
viabil
lab
gastrointestin
transit
vidhyalakshmi
et
al
nowaday
common
techniqu
use
protect
bacteri
cell
degrad
gut
andor
target
antigen
uptak
lymphoid
tissu
galt
encapsul
microparticl
liposom
approach
might
also
enhanc
adhes
form
particl
mucos
surfac
plant
lapatra
provid
possibl
adjuv
properti
induc
local
inflammatori
signal
encapsul
success
appli
preserv
live
vector
vaccin
antigen
anchor
cell
wall
solut
effect
help
avoid
degrad
extern
expos
protein
passag
gastrointestin
tract
git
case
intracellularli
local
antigen
assum
might
need
encapsul
sinc
cell
wall
act
natur
protect
barrier
intestin
environ
simpl
method
preserv
viabil
lab
base
applic
appropri
liquid
carrier
protect
properti
trehalos
jain
roy
szatraj
et
al
strain
mostli
belong
lactobacillu
genu
effect
colon
host
caviti
play
crucial
role
maintain
balanc
natur
microbiota
adhes
properti
consid
import
qualiti
also
recombin
vaccin
ensur
persist
host
possibl
extend
time
antigen
present
immun
system
specif
lactic
acid
bacteri
strain
exhibit
immunomodulatori
effect
human
anim
organ
observ
confirm
also
recombin
lab
cell
produc
variou
antigen
infecti
diseas
allergi
promot
protein
therapeut
antibodi
capron
et
al
although
precis
molecular
mechan
immunomodul
fulli
examin
determin
affect
dendrit
cell
dc
matur
induc
cytokin
secret
receptor
tlr
includ
number
studi
evidenc
role
lab
peripher
hyporespons
promot
regulatori
develop
dc
modul
duboi
et
al
rigaux
et
al
et
al
natur
adjuvant
lab
attract
featur
oral
vaccin
develop
moreov
lab
also
shown
effici
produc
mani
differ
heterolog
antigen
eg
helicobact
pylori
ureas
lcrv
antigen
yersinia
pseudotuberculosi
antigen
human
type
papilloma
viru
haemagglutinin
ha
avian
influenza
viru
et
al
szatraj
et
al
zhou
et
al
mention
aspect
make
lab
attract
promis
host
oral
vaccin
product
deliveri
mani
differ
compound
fig
work
summar
organ
avail
knowledg
ongo
research
applic
lab
heterolog
protein
product
oral
mucos
deliveri
mani
differ
molecul
act
antigen
hope
articl
provid
actual
inform
data
new
possibl
vaccin
develop
especi
oral
administ
formul
also
give
practic
idea
help
plan
lab
vaccin
experi
articl
also
discuss
issu
genet
modif
lead
develop
lab
strain
new
vaccin
potenti
applic
human
anim
medicin
current
research
show
lab
effici
engin
produc
deliv
differ
protein
includ
therapeut
mucos
surfac
popular
antigen
target
galt
although
lymphoid
tissu
nalt
genit
mucos
surfac
valt
also
taken
consider
vaccin
trial
although
nasal
immun
proven
effect
number
studi
falcon
et
al
lee
et
al
oliveira
et
al
hanniffi
et
al
campo
et
al
rout
vaccin
chosen
primarili
respiratori
infecti
diseas
includ
tuberculosi
coronaviru
influenza
respiratori
syncyti
viru
etc
valt
immun
approach
less
suffici
ogra
et
al
requir
addit
stimul
usual
via
oral
path
shown
cholera
vaccin
kozlowski
et
al
interact
lab
vaccin
galt
extens
explor
address
follow
section
git
intens
expos
pathogen
variou
biolog
activ
factor
among
antigen
carcinogen
lymphat
tissu
associ
gut
play
crucial
role
local
system
immun
respons
role
reli
mediat
migrat
home
activ
immun
cell
gut
site
bodi
mucos
immun
system
respons
daili
immunoglobulin
product
lab
among
bacteria
occur
physiolog
anim
human
mainli
digest
tract
ensur
balanc
composit
gut
microflora
particip
factor
regul
mani
physiolog
process
allergi
inflamm
gonzaga
et
al
although
main
role
lab
dairi
food
product
milk
ferment
select
strain
group
bacteria
also
known
effect
includ
enhanc
non
specif
immun
respons
well
control
intestin
infect
activ
action
base
activ
inflammatori
immun
respons
iga
antibodi
product
product
exopolysaccharid
substanc
lab
assur
integr
gut
mucou
membran
also
influenc
distribut
number
lymphoid
cell
lymphat
tissu
associ
gut
howev
molecular
mechan
lab
affect
immun
system
unknown
probabl
lab
alon
product
metabol
absorb
transport
lymphat
follicl
analys
immun
system
mestecki
ernst
et
al
lidbeck
nord
gibson
wang
possibl
lab
directli
impact
gut
epithelium
cell
contain
lymphocyt
abl
produc
wide
scale
cytokin
influenc
local
immun
fig
galdeano
et
al
interact
lab
product
metabol
immunocompet
cell
macrophag
stimul
product
cytokin
hypothes
cytokin
induc
lab
two
possibl
pathway
via
antigen
present
ii
direct
interact
lab
immunocompet
cell
specul
reinforc
fact
lymphocyt
macrophag
equip
specif
receptor
lab
peptidoglycan
fuller
two
differ
scientif
group
prove
peptidoglycan
lab
induc
secret
interleukin
il
stimul
prolifer
induct
differenti
activ
monocyt
fernand
shahani
bhakdi
tranumjensen
dziarski
interferon
induc
express
mhc
class
class
ii
antigen
stimul
lymphocyt
activ
macrophag
enhanc
vaccin
immunogen
heumann
et
al
import
factor
influenc
immunomodul
charact
lab
connect
abil
modul
immun
system
particular
strain
dose
depend
appli
strain
vaccin
scheme
murray
alvarez
de
petrino
et
al
age
physiolog
state
host
regard
immun
modul
import
featur
lab
intern
gut
via
differ
pathway
enabl
induc
differ
immun
respons
interact
lab
activ
mainli
specif
immun
respons
interact
fae
cell
epitheli
cell
induc
nonspecif
inflammatori
respons
contact
lab
epitheli
cell
lead
enhanc
local
immun
et
al
shown
lactobacillu
casei
lactobacillu
delbrueckii
ssp
bulgaricu
lactobacillu
acidophilu
affect
system
humor
immun
respons
attribut
select
appropri
lactobacilli
strain
effect
antigen
carrier
studi
show
choic
specif
lab
oral
administr
crucial
direct
modul
system
immun
respons
accord
observ
cytokin
profil
signific
increas
interleukin
level
observ
mice
fed
lact
delbrueckii
ssp
bulgaricu
lact
casei
turn
induct
observ
case
lact
acidophilu
role
produc
cytokin
balanc
determin
report
lact
casei
lact
delbrueckii
ssp
bulgaricu
increas
respons
favour
lactobacillu
acidophilu
induc
respons
advantag
turn
streptococcu
thermophilu
affect
balanc
studi
also
confirm
effect
variou
lab
strain
stimul
differ
mucos
cytokin
profil
martin
lew
hershberg
mayer
thu
vaccin
develop
select
strain
specif
immunolog
properti
must
well
defin
induc
desir
immun
respons
cytokin
express
lactic
acid
bacteria
strain
induc
also
nonspecif
immun
respons
first
line
defenc
connect
monocyt
macrophag
neutrophil
nk
cell
phagocytosi
lead
intracellular
reaction
product
reactiv
oxygen
nitrogen
radic
well
addit
factor
like
moineau
goulet
balasubramanya
et
al
tizard
result
variou
anim
studi
show
level
phagocyt
cell
function
case
system
immun
respons
secret
lysosom
enzym
macrophag
mice
fed
ferment
milk
contain
lact
casei
effect
compar
anim
supplement
lact
acidophilu
strep
thermophilu
tortuero
fernandez
report
increas
concentr
ileal
tissu
piglet
treat
streptococcu
faecium
lact
casei
spp
histolog
examin
indic
increas
phagocyt
activ
cell
differ
composit
suggest
respons
differ
immunomodul
activ
test
lactobacilli
strain
tortuero
fernandez
moreov
strain
abl
surviv
git
adher
intestin
mucou
membran
report
induc
far
effect
immun
respons
alvarez
stimul
nonspecif
immun
system
ferment
product
probabl
due
peptid
produc
ferment
fiat
et
al
report
et
al
lab
strain
abl
induc
specif
secretori
immun
other
enhanc
gut
inflammatori
immun
respons
lactobacillu
casei
lact
plantarum
shown
interact
peyer
patch
cell
result
increas
iga
cell
specif
antibodi
direct
stimul
strain
turn
lactococcu
lacti
lact
delbrueckii
ssp
bulgaricu
strain
induc
increas
iga
cell
enter
iga
cycl
cell
et
al
lactic
acid
bacteria
strain
also
determin
posit
role
erad
intestin
infect
studi
heria
et
al
gnotobiot
rat
fed
lact
plantarum
combin
escherichia
coli
show
lower
amount
e
coli
small
intestin
caecum
week
colon
compar
group
colon
e
coli
alon
appear
colon
rat
significantli
higher
total
serum
iga
level
slightli
higher
igm
iga
antibodi
level
e
coli
colon
e
coli
alon
heria
et
al
effect
milk
product
enhanc
nonspecif
specif
immun
respons
well
control
intestin
infect
confirm
larg
number
differ
public
nader
de
et
al
report
increas
resist
shigella
infect
mediat
high
titr
antibodi
serum
intestin
secret
mice
fed
ferment
milk
nader
de
et
al
also
et
al
show
correl
increas
immun
respons
resist
salmonella
typhimurium
infect
mice
fed
milk
cultur
et
al
anoth
studi
applic
lact
casei
lact
bulgaricu
report
termin
immunosuppress
mice
candida
albican
infect
de
petrino
et
al
anim
inocul
lactobacilli
show
signific
increas
faecal
secretori
iga
level
compar
control
anim
lee
et
al
accord
alvarez
et
al
cultur
lact
casei
protect
host
salm
typhimurium
infect
first
applic
effect
maintain
simpl
revaccin
day
protect
effect
observ
number
cell
lamina
propria
level
secretori
iga
gut
fluid
increas
alvarez
et
al
correl
elev
number
polymorph
nuclear
cell
induc
inflammatori
immun
respons
note
influenc
mucou
membran
integr
discuss
popul
whole
increas
balanc
maintain
higher
level
cell
popul
could
induc
inflammatori
respons
cytotox
effect
hand
elev
number
peculiarli
popul
could
cytokin
pathway
stimul
enhanc
express
hla
class
ii
event
could
associ
higher
captur
antigen
overstimul
mucu
interestingli
administr
antigen
certain
mucos
region
may
gener
antibodi
distant
mucos
site
kozlowski
et
al
exampl
oral
immun
shown
allow
antigen
uptak
induct
site
oral
caviti
upper
intestin
elicit
antibodi
saliva
intestin
also
mammari
gland
vagin
secret
therefor
seem
oral
vaccin
induc
immun
respons
local
gut
mucos
site
well
system
humor
cellular
immun
respons
de
moreno
de
leblanc
et
al
conclud
effect
local
mucos
immun
lab
broader
rang
elicit
global
immun
respons
antigen
dose
vaccin
protect
also
crucial
issu
live
vaccin
develop
firstli
seem
protein
eg
hepat
b
surfac
antigen
easili
recogn
immun
system
yum
et
al
compound
less
effect
immun
respons
may
provid
effici
protect
type
strain
use
antigen
vehicl
produc
also
import
determin
differ
strain
possess
variou
adjuv
properti
well
differ
adhes
abil
signific
impact
stimul
immun
system
anoth
concern
design
proper
vaccin
scheme
case
oral
administ
vaccin
strategi
requir
one
must
take
account
overdosag
antigen
lead
oral
toler
therefor
appropri
dose
vaccin
scheme
need
separ
optim
chosen
vaccin
system
gener
dose
produc
antigen
rel
high
recogn
nonself
immun
system
host
elicit
protect
respons
still
remain
low
avoid
immunosuppress
regard
age
physiolog
state
host
immunocompromis
patient
less
often
infant
elderli
certain
lab
caus
opportunist
infect
rare
case
connect
often
probiot
prepar
contain
lactobacillu
sp
howev
risk
lactobacillemia
consid
unequivoc
neglig
sander
et
al
moreov
publish
evid
consumpt
oral
administ
lab
vaccin
carri
risk
bacteraemia
probabl
due
signific
differ
dose
well
applic
scheme
probiot
live
vector
vaccin
case
latter
administr
decreas
risk
bacteraemia
lactococcu
lacti
strain
colon
digest
tract
anim
human
mice
microb
resid
h
passiv
transit
observ
human
lactococci
persist
gut
day
klijn
et
al
chamberlain
et
al
havenith
et
al
due
fact
attent
focus
express
variou
antigen
l
lacti
cell
extracellularli
effici
express
system
develop
first
induc
express
system
develop
l
lacti
base
properti
e
coli
bacteriophag
rna
polymeras
plet
vector
system
use
success
intracellular
product
mani
heterolog
antigen
l
lacti
eg
diphtheria
toxin
fragment
b
immunogen
shistosoma
manson
tetanu
toxin
fragment
c
ttfc
well
et
al
robinson
et
al
merceni
et
al
modifi
plet
vector
develop
secret
antigen
mg
extracellular
matrix
anchor
cell
surfac
also
varieti
ttfc
fusion
protein
eg
loop
produc
quit
good
effici
rang
total
solubl
cell
protein
analog
studi
perform
glutathion
parasit
schistosoma
mansoni
capron
et
al
antigen
effici
express
l
lacti
separ
also
fusion
ttfc
immunogen
antigen
proven
vivo
experi
klijn
et
al
chamberlain
et
al
lactococci
also
shown
effici
cytokin
deliveri
vehicl
constitut
express
strain
l
lacti
accumul
ttfc
within
cytoplasm
compart
also
secret
either
murin
test
steidler
et
al
recombin
l
lacti
strain
shown
produc
activ
interleukin
cultur
supernat
level
mg
immun
trial
strain
confirm
strong
adjuv
effect
modifi
live
strain
serum
igg
titr
higher
increas
rapidli
compar
respons
gener
immun
strain
produc
ttfc
alon
contrast
level
immun
respons
enhanc
cytokin
walker
miettinen
et
al
cell
local
express
heterolog
protein
rout
administr
also
crucial
often
correl
immun
respons
level
studi
show
recombin
l
lacti
strain
produc
three
differ
type
ttfc
protein
intracellular
extracellular
abl
subcutan
administr
mice
without
adjuv
evok
protect
lethal
toxin
challeng
michon
et
al
three
type
local
allow
develop
specif
immun
respons
howev
highest
igg
serum
antibodi
titr
obtain
strain
produc
ttfc
cytoplasm
experi
conduct
robinson
et
al
mice
immun
oral
intranas
rout
nasal
inocul
mice
strain
express
ttfc
intracellularli
use
lactococc
system
led
signific
igg
serum
antibodi
respons
protect
lethal
challeng
tetanu
toxin
antibodi
titr
similar
whether
live
inactiv
mitomycin
recombin
l
lacti
cell
use
shown
effect
immun
respons
obtain
mice
immun
oral
l
lacti
strain
produc
ttfc
high
level
express
system
lower
level
robinson
et
al
merceni
et
al
serum
antibodi
respons
isotyp
induc
significantli
elev
level
iga
antibodi
detect
faec
gut
secret
even
though
antibodi
titr
lower
follow
nasal
immun
protect
efficaci
similar
often
high
antibodi
titr
detect
elisa
find
confirm
neutral
assay
base
specif
neutral
antibodi
nab
reflect
actual
protect
efficaci
vaccin
apart
plet
differ
vector
constitut
activ
promot
low
medium
strength
appli
heterolog
gene
express
l
lacti
exampl
vector
use
express
ttfc
protein
effici
total
cell
protein
capron
et
al
kind
vector
suitabl
express
antigen
exhibit
certain
degre
insolubl
toxic
bacteri
cell
exampl
express
system
l
lacti
includ
regul
ptcb
promot
insert
vector
success
use
previou
work
szatraj
et
al
express
differ
kind
viral
ha
gene
vector
appli
kasarello
et
al
experi
connect
oral
administr
l
lacti
express
synthet
gene
myelin
antigen
mani
research
reli
use
commerci
avail
express
system
includ
varieti
differ
vector
adapt
extracellular
protein
express
probabl
often
use
express
system
bacteria
nowaday
kleerebezem
et
al
certain
l
lacti
strain
exhibit
quit
good
persist
git
anim
import
aspect
oral
vaccin
develop
prolong
exposur
particular
antigen
specif
receptor
galt
boguslawska
et
al
report
use
l
lacti
strain
exhibit
abil
persist
effici
git
rat
boguslawska
et
al
examin
identifi
l
lacti
ibb
strain
et
al
led
determin
persist
inextric
connect
adhes
properti
l
lacti
ibb
three
surfac
protein
connect
adhes
describ
date
chromosom
encod
sex
factor
aggreg
protein
clua
two
protein
serin
proteinas
prtp
et
al
protein
display
pilin
characterist
meyrand
et
al
seem
persist
live
bacteri
vaccin
depend
also
host
exampl
strain
suggest
adapt
specif
git
human
anim
ozawa
et
al
strain
possess
increas
adhes
abil
thu
exhibit
high
persist
eg
attract
view
mucos
appli
vaccin
nonetheless
seem
bacteri
persist
gut
featur
determin
strain
host
separ
streptococcu
gordonii
member
endogen
human
microflora
colon
oral
vagin
caviti
persist
transient
digest
tract
natur
compet
genet
express
system
heterolog
protein
surfac
strep
gordonii
strain
call
challi
medaglini
et
al
pouwel
et
al
basi
reli
chromosom
integr
recombin
dna
encod
vaccin
antigen
fuse
surfac
protein
streptococcu
pyogen
system
allow
releas
antigen
medium
present
anchor
form
recombin
protein
rang
size
amino
acid
effect
produc
surfac
strep
gordonii
cell
includ
protein
human
papilloma
viru
type
domain
allergen
hornet
venom
ovalbumin
surfac
protein
f
h
measl
viru
b
subunit
heat
labil
toxin
ltb
e
coli
salminen
et
al
interest
featur
system
recombin
strain
express
cell
surfac
two
differ
antigen
conduct
experi
reveal
use
strain
singl
dose
rang
cfu
led
stabl
colon
oropharyng
mucosa
anim
moreov
antigen
express
stabl
vitro
local
iga
system
igg
antibodi
produc
effect
strep
gordonii
colon
shown
relat
observ
immun
respons
moineau
goulet
tizard
intragastr
immun
strain
produc
ltb
one
describ
far
moineau
goulet
havenith
et
al
contrast
oropharyng
mucosa
shown
strep
gordonii
cell
colon
intestin
mucosa
induc
serum
igg
faecal
iga
subsequ
result
indic
phagocytosi
strep
gordonii
activ
dc
great
advantag
cell
repres
effici
cell
respons
gener
primari
respons
despit
promis
result
indic
potenti
role
strep
system
live
vaccin
vector
develop
still
seriou
safeti
issu
solv
licens
humananim
use
firstli
vector
formerli
classifi
streptococcu
sangui
protein
origin
strep
pyogen
long
time
consid
virul
determin
moreov
system
evok
chromosom
integr
gene
fusion
togeth
associ
drug
resist
marker
constitut
addit
disadvantag
merceni
et
al
spite
still
common
system
use
design
live
vaccin
base
strep
gordonii
ricci
et
al
sharma
et
al
kotloff
et
al
wang
et
al
select
marker
cadmium
resist
gene
also
investig
strep
thermophilu
yet
use
system
doubt
sinc
necessit
use
harm
toxic
compound
cadmium
peterbau
et
al
without
doubt
varieti
safeti
issu
need
resolv
strep
vaccin
licens
human
anim
use
sure
less
controversi
solut
lack
unwarr
marker
sequenc
need
develop
lactobacilli
known
safe
bacteria
possess
number
properti
render
highli
suitabl
deliv
mani
differ
compound
mucosa
immunomodul
capac
lactobacilli
togeth
possibl
target
antigen
product
specif
site
bacteri
cell
seem
attract
featur
two
type
lactobacillu
strain
commens
dietari
may
taken
account
potenti
vaccin
vehicl
commens
strain
expect
combin
properti
abil
adher
area
oral
caviti
stomach
intestin
vagina
urethra
dietari
strain
mainli
use
milk
industri
starter
product
ferment
milk
meat
veget
product
taken
consider
differ
strain
vari
immunomodulatori
characterist
great
impact
intrins
vaccin
potenti
especi
capac
adher
relev
epitheli
surfac
import
properti
adhes
mediat
direct
adher
antigen
sampl
cell
epitheli
cell
mucu
aggreg
resid
bacteria
second
strategi
lead
intens
competit
endogen
bacteri
commun
result
prolong
antigen
exposur
vitro
vivo
model
use
select
screen
adher
lactobacillu
strain
pouwel
et
al
gather
data
indic
colon
even
unlik
one
particular
strain
constitut
ideal
vector
deliv
antigen
differ
host
differ
mucos
caviti
within
host
medaglini
et
al
studi
perform
nonrecombin
chromosom
mark
rifr
smr
lactic
acid
bacteri
strain
lactobacillu
fermentum
kld
lact
plantarum
ncimb
lact
salivariu
ucc
given
oral
human
volunt
ferment
milk
product
show
two
latter
strain
far
superior
abil
surviv
passag
stomach
strain
abl
reach
quit
high
viabl
count
ileum
advantag
regard
local
peyer
patch
merceni
et
al
seem
best
strategi
select
effici
colon
strain
direct
isol
candid
strain
target
host
strain
human
murin
origin
shown
effect
colon
least
two
bodi
caviti
mous
anim
model
lactobacillu
paracasei
vagin
murin
isol
lact
plantarum
ncimb
human
saliva
isol
determin
persist
gut
vagina
week
salminen
et
al
choic
favour
lactobacillu
strain
also
link
strong
select
express
system
havenaar
et
al
merceni
et
al
optim
translat
transcript
target
sequenc
differ
significantli
speci
might
even
well
et
al
lactobacilli
variou
antigen
produc
target
differ
local
cytoplasm
level
percent
total
protein
content
ii
cultur
medium
mg
iii
cell
surfac
gonzaga
et
al
recent
improv
gene
express
includ
develop
plasmid
express
vector
increas
stabil
chromosom
integr
system
target
specif
random
loci
system
mostli
base
differ
nonrepl
altern
recombin
conjug
transposon
well
et
al
latter
offer
possibl
rapidli
test
express
specif
antigen
varieti
recipi
strain
howev
approach
may
lead
integr
carri
antibiot
resist
marker
inactiv
chromosom
gene
essenti
persist
immunomodul
system
base
nonrepl
plasmid
nondisrupt
integr
achiev
locu
describ
dupont
et
al
anoth
integr
vector
especi
suit
lact
plantarum
lead
insert
either
dehydrogenas
locu
construct
merceni
et
al
inactiv
shown
impair
growth
lact
plantarum
vitro
vivo
recombin
plasmid
carri
dna
translat
fusion
gene
integr
plasmid
occur
via
doubl
second
homolog
recombin
lead
resect
contain
heterolog
gene
antibiot
marker
system
exploit
loci
use
success
produc
antigen
lactobacilli
exampl
recombin
transposon
allow
rush
et
al
express
e
coli
ltb
cell
surfac
differ
lactobacilli
integr
gene
allow
higher
product
level
comparison
insert
locu
chromosom
integr
produc
compar
antigen
amount
recombin
strain
carri
multicopi
plasmid
note
improv
express
level
often
reli
modif
translat
initi
region
translat
fusion
endogen
gene
regul
promot
avail
lactobacilli
express
system
origin
design
l
lacti
also
implement
lact
plantarum
ncimb
kleerebezem
et
al
requir
integr
sensor
regulatori
gene
nisk
nisr
chromosom
host
optim
induct
condit
nisin
system
determin
effici
allow
high
express
level
ttfc
gfp
green
fluoresc
protein
aequorea
victoria
sinc
antigen
product
level
control
condit
induct
possibl
investig
effect
antigen
quantiti
level
durat
specif
immun
respons
gfp
strain
requir
addit
exogen
substrat
emit
fluoresc
repres
ideal
tool
perform
studi
vivo
use
confirm
vitro
phagocytosi
macrophag
vivo
intragastr
intranas
administr
mice
geoffroy
et
al
use
gfp
marker
also
appli
track
surviv
strain
environ
although
function
lactobacilli
adjuv
carrier
establish
earli
immunogen
recombin
strain
intraperiton
rout
demonstr
rel
recent
latest
experi
carri
within
labvac
network
confirm
nasal
administr
lactobacilli
produc
ttfc
level
percent
total
cellular
protein
content
includ
lact
plantarum
ncimb
integr
induc
product
serum
igg
local
iga
merceni
et
al
control
comparison
lab
strain
oral
rout
undertaken
well
ongo
work
includ
select
strain
appropri
human
use
identif
adhes
factor
use
antigen
present
merceni
et
al
food
drug
administr
acknowledg
lab
bacteria
gra
statu
mean
safe
use
human
anim
nonetheless
live
vaccin
strain
base
consid
avirul
increas
number
project
aim
assess
biosafeti
lab
polyphas
taxonom
identif
biosafeti
microorgan
human
anim
applic
gener
assess
detect
antibiot
resist
horizont
transfer
antibiot
resist
gene
detect
known
new
virul
properti
evalu
immunolog
advers
effect
surviv
colon
genet
stabil
human
gut
lactococcu
lacti
lactobacilli
gener
classifi
biosafeti
level
strep
gordonii
classifi
class
lab
strain
use
live
vector
vaccin
handl
accord
offici
guidelin
procedur
avail
exampl
cdc
center
diseas
control
prevent
websit
use
genet
modifi
organ
alway
rais
concern
uncontrol
persist
spread
environ
thu
transfer
antibiot
select
marker
genet
sequenc
microb
ignor
especi
mani
effici
method
improv
adapt
skill
conjug
transform
retromobil
transduct
identifi
toomey
et
al
examin
involv
enterococcu
faecali
l
lacti
spread
resist
determin
lab
pathogen
strain
e
coli
listeria
spp
staphylococcu
aureu
salmonella
spp
resist
transfer
note
first
two
strain
transfer
erythromycin
resist
listeria
spp
donor
strain
determin
addit
high
frequenc
erythromycin
transfer
observ
lab
speci
also
mani
strain
lactobacilli
natur
resist
vancomycin
may
evok
question
potenti
transfer
howev
vancomycin
resist
gene
lactobacillu
speci
chromosom
locat
easili
transmit
genera
tynkkynen
et
al
addit
vancomycin
exclud
treatment
lactobacillemia
minim
occurr
nonsuscept
strain
antibiot
spread
resist
onto
bacteria
much
attent
paid
develop
differ
select
marker
meet
requir
specifi
definit
two
main
group
select
marker
replac
routin
use
select
antibiot
resist
classifi
domin
activ
complement
passiv
select
approach
peterbau
et
al
et
al
activ
contain
base
condit
genet
control
either
activ
compound
repress
essenti
gene
passiv
contain
base
mainli
complement
auxotrophi
gene
defect
supplement
either
intact
gene
essenti
metabolit
domin
marker
reli
gene
therefor
wide
applic
often
adapt
sever
differ
lab
speci
exampl
nsr
gene
encod
hydrophob
protein
provid
resist
nisin
one
first
gene
use
altern
domin
select
nisin
immun
gene
nisi
lafi
gene
encod
immun
class
ii
bacteriocin
lactacin
f
also
success
use
select
marker
heterolog
host
recent
domin
select
marker
base
bile
salt
hydrolas
gene
bsh
lact
plantarum
report
jarocki
et
al
anoth
exampl
domin
select
exploit
gene
involv
util
rare
unusu
sugar
like
catabol
encod
gene
xylrab
gene
sucros
gene
scra
scrb
second
type
marker
base
complement
select
involv
select
hostvector
system
system
base
complement
specif
mutat
chromosom
gene
essenti
particular
metabol
pathway
known
mutat
nonsens
mutat
purin
biosynthet
pathway
combin
nonsens
suppressor
ochr
suppressor
gene
supb
delet
intern
fragment
chromosom
alr
gene
mutat
thya
gene
mutat
chromosom
lactos
operon
variou
lab
complement
system
often
bacteriostat
rather
bactericid
among
two
system
potenti
human
applic
distinguish
first
one
base
alanin
racemas
mutant
requir
gener
larg
number
lab
strain
second
one
reli
thymidin
synthas
thya
mutant
l
lacti
potenti
situat
genet
modifi
strain
would
releas
environ
transgen
elimin
genom
strain
revert
l
lacti
exampl
steidler
et
al
steidler
replac
thya
synthet
human
transgen
result
creation
strain
valid
studi
pig
strain
approv
netherland
experiment
therapi
human
inflammatori
bowel
diseas
ibd
would
great
interest
determin
specif
doubl
mutant
could
offer
addit
benefit
singl
thya
mutat
increas
antigen
express
presenc
two
transgen
copi
redund
respect
biolog
contain
applic
mutant
use
differ
kind
transgen
steidler
et
al
steidler
special
subgroup
hostvector
system
induc
gene
express
system
like
nice
express
system
system
base
quorum
sens
psip
vector
develop
base
promot
regulatori
gene
class
ii
bacteriocin
sakacin
sap
gene
cluster
sakacin
p
spp
gene
cluster
possibl
select
adequ
express
vector
select
marker
divers
howev
final
step
toward
system
remov
replac
undesir
part
express
vector
yet
report
peterbau
et
al
et
al
anoth
issu
address
design
administr
scheme
live
vaccin
especi
via
oral
rout
phenomenon
mucos
toler
mowat
weiner
oral
toler
state
local
system
immun
unrespons
induc
oral
administr
antigen
system
hyporespons
also
induc
administr
antigen
via
nasal
rout
level
molecular
mechan
proper
balanc
maintain
order
elicit
effect
immun
respons
duboi
et
al
rise
sole
lead
inflamm
increas
result
overstimul
appear
mucos
toler
appear
induct
mucos
toler
mucos
immun
occur
site
gut
mucos
lymphoid
site
case
mucos
toler
serv
benefici
function
ogra
et
al
diseas
oral
immun
shown
suppress
autoimmun
respons
eg
rheumatoid
arthriti
multipl
sclerosi
experiment
autoimmun
enceph
myeliti
uveoretin
diabet
mellitu
inform
clinic
trial
connect
lab
vaccin
limit
biolog
contain
strategi
prerequisit
market
live
bacteri
vaccin
vector
lack
major
reason
restrict
develop
field
howev
system
establish
l
lacti
use
therapeut
deliveri
human
alreadi
undergon
phase
ii
clinic
trial
treatment
ibd
steidler
recombin
l
lacti
strain
term
develop
clinic
use
actogenix
compani
spite
seriou
safeti
issu
also
strep
gordonii
use
phase
clinic
trial
demonstr
organ
safe
administ
human
nasalor
rout
kotloff
et
al
still
develop
new
stabl
auxotroph
lab
strain
abl
replic
human
bodi
safe
use
even
immun
compromis
individu
highli
desir
select
colon
vs
noncolon
vaccin
speci
strain
crucial
step
design
vaccin
one
side
vivo
synthesi
antigen
bacteria
persist
desir
mucos
surfac
effici
stimul
immun
system
due
prolong
exposur
antigen
hand
noncolon
lab
act
live
microparticl
preload
antigen
releas
transit
gut
possibl
univoc
predict
system
better
accord
optim
antigen
present
paramet
known
affect
immunogen
strain
abl
effici
colon
human
need
select
basi
safeti
physiolog
metabol
criteria
vaccin
strain
genet
stabl
allow
express
protect
epitop
differ
cellular
locat
immunolog
point
view
analysi
immun
respons
natur
intens
accord
mode
antigen
present
immun
rout
natur
bacteri
vector
well
character
essenti
final
effect
two
research
network
contract
focus
common
model
system
organ
examin
potenti
three
lab
vaccin
vehicl
l
lacti
prototyp
noncolon
strain
lactobacilli
colon
bacteria
strep
gordonii
oral
commens
bacterium
stabl
antigen
present
system
merceni
et
al
mention
project
concentr
examin
product
antigen
bacteri
viral
origin
three
bacteria
first
antigen
use
ttfc
kda
nontox
polypeptid
domain
use
model
antigen
due
immunogen
avail
lethal
mous
challeng
model
fairweath
et
al
allow
effect
evalu
capabl
mucos
deliveri
system
elicit
system
humor
immun
respons
second
examin
antigen
protein
porcin
pseudorabi
viru
aujeszki
diseas
viru
adv
pathogen
infect
anim
respiratori
tract
best
way
inactiv
induct
mucos
immun
respons
approach
design
evalu
potenti
three
select
lab
target
viral
diseas
addit
challeng
mice
pig
adv
enabl
evalu
bioactiv
induc
antibodi
respons
merceni
et
al
thank
inform
gather
frame
project
knowledg
characterist
properti
three
examin
lab
speci
mucos
vaccin
updat
unifi
organ
lactic
acid
deliveri
express
system
consid
promis
tool
effici
product
antigen
mani
biolog
activ
compound
crucial
aspect
taken
account
design
effect
mucos
vaccin
manifold
despit
numer
studi
use
lab
potenti
vaccin
vehicl
necessari
broaden
knowledg
immun
effect
local
mucos
applic
group
bacteria
antigen
level
may
produc
develop
effect
mucos
administr
vaccin
also
inextric
link
understand
immun
respons
mechan
cellular
molecular
pathway
involv
control
comprehens
knowledg
type
induc
cell
immun
respons
role
cytokin
phagocyt
function
would
help
current
hope
direct
new
system
product
immunogen
antigen
target
specif
area
cell
even
receptor
develop
recombin
lab
vaccin
earli
stage
fortun
specif
immunolog
experi
new
recombin
strain
vector
continu
construct
describ
detail
lead
near
futur
standard
lab
vector
vaccin
product
author
declar
conflict
interest
